Cyclophosphamide administration routine in autoimmune rheumatic diseases: a review.

about

Ganetespib synergizes with cyclophosphamide to improve survival of mice with autochthonous tumors in a mutant p53-dependent manner.

P2860

Q42292365-8076AF67-2A0F-4A17-8006-78BBAE44E215

P2860

Cyclophosphamide administration routine in autoimmune rheumatic diseases: a review.

Item

http://www.wikidata.org/entity/Q38969688

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

Cyclophosphamide administration routine in autoimmune rheumatic diseases: a review.

@en

type

Item

label

Cyclophosphamide administration routine in autoimmune rheumatic diseases: a review.

@en

prefLabel

Cyclophosphamide administration routine in autoimmune rheumatic diseases: a review.

@en

P1476

Cyclophosphamide administration routine in autoimmune rheumatic diseases: a review.

@en

P2093

Bruno Gedeon de Araújo

http://www.w3.org/2001/XMLSchema#string

Francisco Aires Correa Lima

http://www.w3.org/2001/XMLSchema#string

Kaian Amorim Teles

http://www.w3.org/2001/XMLSchema#string

Patrícia Medeiros-Souza

http://www.w3.org/2001/XMLSchema#string

Rodrigo Aires Correa Lima

http://www.w3.org/2001/XMLSchema#string

P2860

Cyclophosphamide cystitis--identification of acrolein as the causative agent

Mesna versus hyperhydration for the prevention of cyclophosphamide-induced hemorrhagic cystitis in bone marrow transplantation

Guidelines for antiemetic treatment of chemotherapy-induced nausea and vomiting: past, present, and future recommendations.

[Assessing the economic impact of adverse events in Spanish hospitals by using administrative data].

Incidence and prevention of bladder toxicity from cyclophosphamide in the treatment of rheumatic diseases: a data-driven review.

Effect of age, menopause and cyclophosphamide use on damage accrual in systemic lupus erythematosus patients from LUMINA, a multiethnic US cohort (LUMINA LXIII).

Modification of the pharmacokinetics of high-dose cyclophosphamide and cisplatin by antiemetics.

[Rational drug use: an economic approach to decision making].

Cyclophosphamide pharmacokinetics and dose requirements in patients with renal insufficiency.

Water intoxication induced by low-dose cyclophosphamide in two patients with systemic lupus erythematosus.

P2888

j.rbr.2016.04.009

P31

scholarly article

P356

10.1016/J.RBR.2016.04.009

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1003074259

http://www.w3.org/2001/XMLSchema#string

P698

27693178

http://www.w3.org/2001/XMLSchema#string

Cyclophosphamide administration routine in autoimmune rheumatic diseases: a review.

about

P2860

P2860

Cyclophosphamide administration routine in autoimmune rheumatic diseases: a review.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P6179

P698